Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
+544K
-
Total reported value, excl. options
-
$75.9M
-
Value change
-
+$2.92M
-
Number of buys
-
41
-
Number of sells
-
-30
-
Price
-
$4.80
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2020
91 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q4 2020.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 79.8M outstanding shares and own 19.82% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.9M shares), VANGUARD GROUP INC (2.44M shares), ICONIQ Capital, LLC (1.71M shares), Tieton Capital Management, LLC (1.15M shares), Uniplan Investment Counsel, Inc. (1.08M shares), MORGAN STANLEY (722K shares), Sycale Advisors (NY) LLC (714K shares), STATE STREET CORP (714K shares), GEODE CAPITAL MANAGEMENT, LLC (656K shares), and NORTHERN TRUST CORP (478K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.